Chinese biopharmaceutical company Everest Medicines Ltd announced on Monday a strategic partnership with Canadian biotechnology company Providence Therapeutics Holdings Inc in an effort to develop mRNA COVID-19 vaccines.
Under the partnership, Everest is licensed rights to Providence's mRNA COVID-19 vaccine candidates in Asian emerging markets, including China, Southeast Asia and Pakistan....
